Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Docetaxel and exisulind in hormone-refractory prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Docetaxel and exisulind in hormone-refractory prostate cancer.
Docetaxel and exisulind in hormone-refractory prostate cancer. Semin Oncol. 2001 Aug; 28(4 Suppl 15):56-61.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Humans
Male
Middle Aged
Paclitaxel
Prostate-Specific Antigen
Prostatic Neoplasms
Sulindac
Survival Analysis
Taxoids
authors with profiles
Walter M. Stadler